MBX Biosciences, Inc. (MBX)
NASDAQ: MBX · Real-Time Price · USD
33.77
+0.55 (1.66%)
Apr 17, 2026, 4:00 PM EDT - Market closed
MBX Biosciences Market Cap
MBX Biosciences has a market cap or net worth of $1.6 billion as of April 17, 2026. Its market cap has increased by 588.69% in one year.
Market Cap
1.60B
Enterprise Value
1.23B
1-Year Change
588.69%
Ranking
Category
Stock Price
$33.77
Market Cap Chart
Since the IPO on September 13, 2024, MBX Biosciences's market cap has increased from $509.66M to $1.60B, an increase of 214.80%. That is a compound annual growth rate of 105.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 1.60B | 13.29% |
| Dec 31, 2025 | 1.42B | 129.95% |
| Dec 31, 2024 | 615.88M | 20.84% |
| Sep 13, 2024 | 509.66M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Biohaven | 1.65B |
| Nanobiotix | 1.64B |
| Oculis Holding AG | 1.62B |
| Damora Therapeutics | 1.60B |
| Immunocore Holdings | 1.59B |
| Iovance Biotherapeutics | 1.59B |
| Generate Biomedicines | 1.59B |
| Monte Rosa Therapeutics | 1.58B |